any reason for share price wilting?, page-11

This is a fair point, and one I have been an advocate of as well. People need to understand that the vax arm is a research division, and we've been funding it. There could be some great, potentially very valuable research going on there.

Question as to if this remains a sole holding of Admedus or it gets spun off or sold off are valid questions that should be answered soon - I believe management are working on these questions.

But I would also make the point that, even if we get external funding, vax arm would still cast a shadow over the company as the responsibilities are not clearly defined legally. This may just be something that needs to be solved by drawing a clear legal line between vax and the rest of the company.

And there's nothing wrong with that. What's odd, is that many on here claim to be invested for Regen/CC and Medical Devices, but absolutely balk at talk of spinning off vaccines. That doesn't make sense.